Treatment of Relapsed Chronic Subdural Hematoma in Four Young Children with Atorvastatin and Low‐dose Dexamethasone

Citations Over TimeTop 11% of 2019 papers

Abstract

Chronic subdural hematoma (CSDH) can develop in children in rare cases. Burr-hole drainage (BHD) is the treatment of choice, but it is associated with a high rate of recurrence. This report describes four cases of pediatric patients (1-7 yrs of age) with post-BHD relapsed CSDH who were successfully treated with a drug regimen that included 2.5-5 mg atorvastatin daily combined with dexamethasone with stepwise-decreasing dosing for a total of 4 weeks. After 4 weeks of treatment, the hematoma was completely resolved in three patients and significantly reduced in one patient. During the treatment, no patient reported clinically significant adverse events. No patient experienced hematoma relapse during the follow-up period that lasted for up to 4 years. This case report suggests the need for a randomized placebo-controlled trial to evaluate this drug regimen for nonsurgical treatment of patients with relapsed CSDH.

Related Papers

• → Effects of atorvastatin on chronic subdural hematoma(2017)79 cited
• → Radiological predictors of recurrence of chronic subdural hematoma(2018)25 cited
• [A case of calcified chronic subdural hematoma wherein MRI was useful for decision of the treatment strategy].(2014)
• → The Effects of Dexamethasone Used in the Treatment of Chronic Subdural Hematoma(2022)1 cited
• Contralateral development of chronic subdural hematoma after evacuation of chronic subdural hematoma. A case report.(2006)